| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |